How to incorporate new agents and immunotherapy into the stage III treatment paradigm?

Date 17 April 2015
Event ELCC 2015
Session Locally-advanced NSCLC: Addressing the challenges of large-volume disease
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Locally Advanced
Cancer Immunology and Immunotherapy
Presenter Rafal Dziadziuszko
Authors R. Dziadziuszko
  • Dept. Of Oncology And Radiotherapy, Medical University of Gdansk, 80-211 - Gdansk/PL